HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Enforcement On COVID-19 Consumer Health Fraud Circles Back To Ayurvedic Products

Executive Summary

Georgia firm promoted a product as interrupting “infection chain” of coronavirus. Total of fraudulent COVID-19 claims FDA’s found in consumer health space approaches 200.

You may also be interested in...



US Supplement Firm Warned About Phenibut After Failing To Pull PTSD, Detox, Anxiety Claims

Latest FDA warning to Chill6 doesn’t reference previous letter but lists larger number of violations along with more details about the problems. Agency also recently added salt scrub therapies to its list of products as marketed with fraudulent coronavirus treatment claims.

US Courts Reject Reinstating FDA's Homeopathic Drug Policy As Challenge To Change Proceeds

Decisions in US Circuit and District courts for District of Columba are on complaint by Rx drug firm MediNatura, but should resonate for OTC homeopathic firms as well as all businesses across the sector. MediNatura appealed district ruling rejecting request for injunction against FDA’s withdrawal of 1988 homeopathic CPG.

US Pandemic Fraud Reports To FTC Spark Warnings Against IV Drip Services, Sonar Treatment Provider

Complaints about potentially false COVID-19 claims are one source for FTC investigations to determine whether warnings or other enforcement are warranted. FTC's Consumer Sentinel Network includes nearly 10,000 pandemic fraud complaints, including reports of alleged losses from payments for goods and services not delivered or provided.

Related Content

Topics

UsernamePublicRestriction

Register

RS151696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel